|
⚲
|
| Keyboard |
| Invus Global Management LLC
✚
|
|
|---|---|
| CIK # | 0002005369 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002005369] | |
| 4 | [0002005369] | |
| SC 13G | [0002005369] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexicon Pharmaceuticals Inc LXRX
Series B Convertible Preferred Stock
|
2026-02-02 | Grant | 367,145.12 | $65.00 | 23,864,433 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-02 | Grant | 18,553,846 | $1.30 | 24,120,000 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-02 | Grant | 3,846,154 | $1.30 | 5,000,000 |
|
Lexicon Pharmaceuticals Inc LXRX
Common Stock
|
2026-02-02 | Buy | 1,538,462 | $1.30 | 2,000,001 |
|
Scholar Rock Holding Corp SRRK
Warrant (right to buy) · derivative
|
2025-12-11 | Option exercise | 1,575,008 | $0.00 | |
|
Scholar Rock Holding Corp SRRK
Common Stock
|
2025-12-11 | Option exercise | 1,575,008 | $7.35 | 11,576,309 |
|
Scholar Rock Holding Corp SRRK
Common Stock
|
2024-12-10 | Sell | 1,600,000 | $41.65 | 66,640,000 |
|
Scholar Rock Holding Corp SRRK
Common Stock
|
2024-11-25 | Sell | 43,887 | $38.43 | 1,686,577 |
|
Scholar Rock Holding Corp SRRK
Common Stock
|
2024-11-25 | Sell | 208,272 | $37.63 | 7,837,275 |
|
Scholar Rock Holding Corp SRRK
Common Stock
|
2024-11-25 | Sell | 126,442 | $39.51 | 4,995,723 |
|
Scholar Rock Holding Corp SRRK
Common Stock
|
2024-11-25 | Sell | 149 | $40.98 | 6,106 |
|
Scholar Rock Holding Corp SRRK
Common Stock
|
2024-11-25 | Sell | 30,683 | $40.14 | 1,231,616 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-08-08 | Sell | 260,873 | $0.19 | 49,566 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-08-07 | Sell | 61,488 | $0.18 | 11,068 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-08-06 | Sell | 55,732 | $0.18 | 10,032 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-08-05 | Sell | 164,523 | $0.19 | 31,259 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-08-02 | Sell | 286,200 | $0.20 | 57,240 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-08-01 | Sell | 63,564 | $0.22 | 13,984 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-07-30 | Sell | 756,835 | $0.22 | 166,504 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-07-29 | Sell | 363,949 | $0.24 | 87,348 |
| showing 20 of 21 most recent transactions | |||||